Some Gastroenterology Patients Need a 3rd COVID Vaccine Even Sooner
Recent CDC guidelines recommend patients who are immunocompromised receive a 3rd COVID-19 vaccine. This is for patients who have received a vaccine made by Pfizer or Moderna. The shot should be received at least 28 days after your second vaccine. The vaccine should be the same brand as your first two vaccines, if possible.
Why is a 3rd shot recommended for immunocompromised people?
People who are immunocompromised may not have a strong enough immune response to the first two vaccines. A third vaccine injection can help the immune system respond better. This provides better protection from COVID-19.
How do I know if I am immunocompromised?
Many gastroenterology patients take medications that can cause you to be immunocompromised. These include:
- Biologic agents such as:
- Anti-metabolites such as:
- Xeljanz (tofacitinib)
- Zeposia (ozanimod)
- Prednisone 20mg or higher daily
Additionally, if you are being treated for cancer or have been diagnosed with primary immunodeficiency, then you may be immunocompromised. People who have received an organ transplant or stem cell transplant and take medications to prevent rejection are also considered to be immunocompromised.
What if I received the Johnson and Johnson vaccine?
There is not enough information at this time to know if an immunocompromised person will need a second vaccination. The CDC is currently not recommending a second vaccination at this time.
What if I am not immunocompromised?
At this time, the CDC recommends that people with a normal immune system receive a booster 8-9 months after their second vaccination.
What additional resources are there?
The Center for Disease Control and Texas Health and Human Services websites offer vaccine availability information and FAQ’s that can help guide your vaccination decisions.
If you have questions about your immune system, medications you are taking, and whether you need a 3rd COVID-19 vaccine, call today (210-614-1234) or submit your question through the portal.